IL-6/SOLUBLE IL-6-RECEPTOR (SIL-6R) MEDIATE 2 DISTINCT SIGNALING PATHWAYS IN OSTEOBLASTS THROUGH GP130

被引：0
|
作者：
NISHIMURA, R
YASUKAWA, K
MUNDY, GR
YONEDA, T
机构：
[1] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
[2] TOSO,KANAGAWA,JAPAN
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1995年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [31] Impairment of gingival fibroblast adherence by IL-6/sIL-6R
    Naruishi, K
    Takashiba, S
    Nishimura, F
    Chou, HH
    Arai, H
    Yamada, H
    Murayama, Y
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (05) : 1421 - 1424
  • [32] Circulating IL-6 and sIL-6R in patients with hepatocellular carcinoma
    Giannitrapani, L
    Cervello, M
    Soresi, M
    Notarbartolo, M
    La Rosa, M
    Virruso, L
    D'Alessandro, N
    Montalto, G
    HORMONE-RELATED TUMORS: NOVEL APPROACHES TO PREVENTION AND TREATMENT, 2002, 963 : 46 - 52
  • [33] THE MEMBRANE DISTAL HALF OF GP130 IS RESPONSIBLE FOR THE FORMATION OF A TERNARY COMPLEX WITH IL-6 AND THE IL-6 RECEPTOR
    HORSTEN, U
    SCHMITZVANDELEUR, H
    MULLBERG, J
    HEINRICH, PC
    ROSEJOHN, S
    FEBS LETTERS, 1995, 360 (01) : 43 - 46
  • [34] Circulating soluble gp130, soluble IL-6R, and IL-6 in patients undergoing cardiac surgery, with or without extracorporeal circulation
    Corbi, P
    Rahmati, M
    Delwail, A
    Potreau, D
    Menu, P
    Wijdenes, J
    Lecron, JC
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 18 (01) : 98 - 103
  • [35] Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
    Jones, Simon A.
    Scheller, Juergen
    Rose-John, Stefan
    JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (09): : 3375 - 3383
  • [36] Discovery and characterization of a monoclonal antibody taroeting a conformational epitope of IL-6/IL-6Rα to inhibit IL-6/IL-6Rα/gp130 hexameric signaling complex formation
    Chou, Chun-Chi
    Hua, Kuo-Tai
    Chen, Min-Wei
    Wu, Chin-Jui
    Hsu, Chun-Hua
    Wang, Jann-Tay
    Hsiao, Michael
    Wei, Lin-Hung
    MABS, 2022, 14 (01)
  • [37] TRAF adaptors limit IL-6 receptor signaling through an unexpected binding to the signaling transducer receptor gp130
    So, T.
    Nagashima, H.
    Okuyama, Y.
    Hayahi, T.
    Asao, A.
    Kawabe, T.
    Yamaki, S.
    Nakano, H.
    Croft, M.
    Ishii, N.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 23 - 24
  • [38] HUMAN SOLUBLE INTERLEUKIN-6 RECEPTOR (SIL-6R) FROM MYELOMA CELLS POTENTIATES IL-6 ACTIVITY
    LUST, JA
    JELINEK, DF
    FREDERICK, LA
    HUNTLEY, BK
    BRAATEN, JK
    MAIHLE, NJ
    BLOOD, 1993, 82 (10) : A200 - A200
  • [39] Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors
    Kimura, T
    Wang, JF
    Minamiguchi, H
    Fujiki, H
    Harada, S
    Okuda, K
    Kaneko, H
    Yokota, S
    Yasukawa, K
    Abe, T
    Sonoda, Y
    STEM CELLS, 2000, 18 (06) : 444 - 452
  • [40] Serum levels of SIL-6R and GP130 in PMR patients: Prognostic value of SIL-6R levels in patients with relapses
    Pulsatelli, L.
    Boiardi, L.
    Consonni, D.
    Dolzani, P.
    Silvestri, T.
    Macchioni, P.
    Cantini, F.
    Facchini, A.
    Salvarani, C.
    Meliconi, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 380 - 381
12345